[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368461-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368461-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","linc00908-inactivates-wnt-catenin-signaling-pathway-to-inhibit-prostate-cancer-cell-stemness-via-upregulating-gsk3b-and-fbxw2","LINC00908 Inactivates Wnt/β-Catenin Signaling Pathway to Inhibit Prostate Cancer Cell Stemness via Upregulating GSK3B and FBXW2","","Chemotherapy and androgen-deprivation therapy suppress prostate cancer progression, yet resistance and metastasis persist despite decades of progress. Cancer stem cell theory links relapse, metastasis, and drug resistance to distinct molecular programs, and noncoding RNAs can shape these processes. This study investigates how LINC00908 affects prostate cancer cell stemness and defines its major molecular mechanism using functional assays and bioinformatics evaluation, focusing on regulatory links to HDAC2-p300-YY1, miR-3179, GSK3B, FBXW2, and β-catenin/Wnt pathway activity.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/linc00908-inactivates-wnt-catenin-signaling-pathway-to-inhibit-prostate-cancer-cell-stemness-via-upregulating-gsk3b-and-fbxw2/368461/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/linc00908-inactivates-wnt-catenin-signaling-pathway-to-inhibit-prostate-cancer-cell-stemness-via-upregulating-gsk3b-and-fbxw2/368461.png","ImageObject",300,407,{"name":42,"@type":43},"WPS_1786070896","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What clinical problem does the study address in prostate cancer?","Question",{"text":63,"@type":64},"The study addresses persistent drug resistance and metastasis that limit the effectiveness of chemotherapy and androgen-deprivation therapy.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does LINC00908 influence prostate cancer cell stemness?",{"text":68,"@type":64},"LINC00908 is low-expressed in prostate cancer cells and suppresses prostate cancer cell stemness and tumor growth.",{"name":70,"@type":61,"acceptedAnswer":71},"What molecular mechanism is proposed for LINC00908’s effects?",{"text":72,"@type":64},"LINC00908 down-regulation is mediated by the HDAC2-p300-YY1 transcription complex, and it increases GSK3B via sponging miR-3179, leading to β-catenin ubiquitination and Wnt pathway inactivation through GSK3B/FBXW2 regulation.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368461,1790338553,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},549768072016,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Cancer Medicine  \n|  RESEARCH ARTICLE  OPEN ACCESS \u003Cbr>LINC00908 Inactivates Wnt/β-Catenin Signaling Pathway to Inhibit Prostate Cancer Cell Stemness via Upregulating GSK3B and FBXW2\u003Cbr>Han Guan1,2  | Qiang Hu2 | Lilin Wan2  | Can Wang2 | Yifeng Xue3 | Ninghan Feng4  | Chenggui Zhao5 | Ming Chen2 | Zonghao You2,6 \u003Cbr>1Department of Urology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China | 2Department of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing, China | 3Department of Urology, Changzhou JinTan First People's Hospital, Changzhou, China | 4Department of Urology, Wuxi No. 2 Hospital, Nanjing Medical University, Wuxi, China | 5Department of Laboratory, Affiliated Zhongda Hospital of Southeast University, Nanjing, China | 6Institute of Medical Phenomics Research, Affiliated Zhongda Hospital of Southeast University, Nanjing, China\u003Cbr>Correspondence: Chenggui Zhao ([zhaochenggui@163.com](zhaochenggui@163.com)) | Ming Chen ([mingchen0712@seu.edu.cn](mingchen0712@seu.edu.cn)) | Zonghao You ([18251971231@163.com](18251971231@163.com))\u003Cbr>Received: 28 August 2023 | Revised: 31 March 2024 | Accepted: 10 September 2024\u003Cbr>Funding: This work was supported by the National Natural Science Foundation of China (Nos. 81672551, 81872089, and 82102799), Natural Science Foundation of Jiangsu Province (No. BK20210230), Doctor of Entrepreneurship and Innovation in Jiangsu Province (No. JSSCBS20210138), The General Project of Medical Research of Jiangsu Health and Wellness Committee (No. M2020049), 2020 Provincial Natural Youth Project (No. 2008085QH358), the subject was Molecular mechanism ofTAM exosomes derived miRNAs regulating EMT in prostate cancer cells; First Affiliated Hospital of Bengbu Medical College Science Fund for Outstanding Young Scholars (No. 2019BYYFYYQ09); Changzhou Health Commission Project (ZD2020034); “512 Talent Cultivation Program” of Bengbu Medical College (by51202306) .\u003Cbr>Keywords: β-catenin | DDX3X | FBXW2 | GSK3B | LINC00908 | prostate cancer | stemness |\n| --- |\n| \u003Cbr>ABSTRACT\u003Cbr>Background: Chemotherapy and androgen-deprivation treatment are the curative approaches utilized to suppress prostate cancer (PCa) progression. However, drug resistance and metastasis are extensive and hard to overcome even though remarkable progress has been made in recent decades. The cancer stem cell-related theoretical model explains the distinct molecular characteristics of cancer, its relapse, metastasis, and drug resistance. Meanwhile, noncoding RNA functions in the formation of drug resistance and metastasis in most cancers. The long intergenic nonprotein coding RNA 908 (LINC00908) has been reported torestrain cell proliferation, migration, and invasion of some cancers like triple-negative breast cancer, diffuse large B-cell lymphoma, PCa, and so on. However, its role in stemness for PCa remains unclear.\u003Cbr>Methods: We delved into the impact of LINC00908 in PCa cell stemness and the principal molecular mechanism. Then, the impact of LINC00908 on PCa cell stemness and its corresponding mechanism was explored by using functional assays and bioinformatics evaluation.\u003Cbr>Results: We found that LINC00908 was low-expressed in PCa cells, and it exerted suppressive functions in PCa cell stemness and tumor growth. Additionally, we revealed that LINC00908 down-regulation was mediated by the HDAC2-p300-YY1 transcription complex. Moreover, LINC00908 up-regulated glycogen synthase kinase 3 beta (GSK3B) via sponging miR-3179. |\n| Abbreviations: 3′UTR, 3′untranslated regions; ActD, actinomycin D; ceRNA, competing endogenous RNA; ChIP, chromatin immunoprecipitation; CHX, cycloheximide; CSCs, cancer stem cells; DDX3X, DEAD-box helicase 3 X-linked; FBS, fetal bovine serum; FBXW2, F-box and WD repeat domain containing 2; FISH, fluorescent in situ hybridization; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GSK3B, glycogen synthase kinase 3 beta; HDAC2, histone deacetylase 2; HEK293T, human embryonic ","cbCaihCbeZGjcSUP","https://ap.wps.com/l/cbCaihCbeZGjcSUP","pdf",2941798,18,"English","# Background\n# Methods\n# Results\n# Conclusion\n# Introduction\n# Abstract","[{\"question\":\"What clinical problem does the study address in prostate cancer?\",\"answer\":\"The study addresses persistent drug resistance and metastasis that limit the effectiveness of chemotherapy and androgen-deprivation therapy.\"},{\"question\":\"How does LINC00908 influence prostate cancer cell stemness?\",\"answer\":\"LINC00908 is low-expressed in prostate cancer cells and suppresses prostate cancer cell stemness and tumor growth.\"},{\"question\":\"What molecular mechanism is proposed for LINC00908’s effects?\",\"answer\":\"LINC00908 down-regulation is mediated by the HDAC2-p300-YY1 transcription complex, and it increases GSK3B via sponging miR-3179, leading to β-catenin ubiquitination and Wnt pathway inactivation through GSK3B/FBXW2 regulation.\"}]","LINC00908 Inactivates Wnt/β-Catenin Signaling Pathway to Inhibit Prostate Cancer Cell Stemness via Upregulating GSK3B and FBXW2 | PDF",1790177056,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/23fd7b0a2ae82a104332cb8045497089.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ad92963e4b3521e5f3948b2b6ebf32b4.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e2fc1910e2f16435bff20b52e8ad4edf.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b4f497c959bb225e7a4dd05dab7a71af.webp",980,1287]